Prospective, Split-mouth, Comparative Study to Compare Clinical Outcomes of Two Different Posterior Composite


The objective of this 2-year split mouth comparative study, a randomized controlled study, is to determine whether the simplified placement procedure of the ultra-rapid polymerizing Tetric PowerFlow/ Tetric PowerFill with a reduced light polymerization time (3 s), yields the same clin-ical results as widely used commercially available dental composites (Tetric EvoCeram Bulk Fill, Tetric EvoFlow Bulk Fill) requiring up to 40 seconds of light polymerization time.

Full Title of Study: “A 24-Month Clinical Evaluation of an Ultra-rapid Polymerizing Resin Composite”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: May 31, 2021

Detailed Description

Patients, requiring posterior tooth restorations Class I and II or requesting amalgam restoration replacement, were treated in the clinical investigation. Each patient received two composite restorations in the posterior region.


  • Device: Direct restorative treatment with fast-curing composites (Tetric PowerFill/ Tetric PowerFlow)
    • Tooth (teeth) affected by dental caries or with an existing defective filling will be restored. Adhese Universal in self-etch mode, was used to prepare the surfaces for the composite fillings. Tetric PowerFill/ Tetric PowerFlow (test group) was cured for 3 s.
  • Device: Direct restorative treatment with conventionally applied composites (Tetric EvoCeram Bulk Fill/ Tetric EvoFlow Bulk Fill)
    • Tooth (teeth) affected by dental caries or with an existing defective filling will be restored. Adhese Universal in self-etch mode, was used to prepare the surfaces for the composite fillings. Tetric EvoCeram Bulk Fill/ Tetric EvoFlow Bulk Fill (control group) were conventionally cured for 10 s per increment.

Arms, Groups and Cohorts

  • Experimental: Fast-curing composites
  • Other: Conventionally applied composites

Clinical Trial Outcome Measures

Primary Measures

  • post-operative tooth sensitivity
    • Time Frame: Baseline to 24 months
    • assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 “No pain at all” – 10 “The worst pain imaginable”) following the FDI criteria on a scale from 1 “very good” to 5 “unacceptable”

Secondary Measures

  • restoration quality evaluation
    • Time Frame: Baseline to 24 months
    • assessed following the FDI criteria on a scale from 1 “very good” to 5 “unacceptable”

Participating in This Clinical Trial

Inclusion Criteria

  • Each subject must need at least 2 restorations in a vital posterior tooth (in different quadrants) – Restorations may be indicated for caries removal and restoration, replacement of defec-tive restorations (i.e. fractured, stained, unaesthetic), or requested replacement of un-aesthetic restorations. – Must have given written consent to participate in the trial – Must be available for the required follow-up visits over 2 years – Restored teeth must have occlusal contact with opposing teeth or restored teeth – Restoration width should be equal to or greater than 1/3 the distance from buccal to lin-gual cusp tips – 75% of the restorations Class II (minimum) and 25% Class I – One, two or three surfaces per restoration – Each Class II will have at least one proximal contact – 75% in molars (minimum) and 25% in premolars – All restored teeth must have at least one occlusal contact in habitual closure – Must have 20 or more teeth with evidence of bilateral posterior tooth contacts – Teeth that require one or no cuspal build-ups – Vital tooth – Preoperative sensibility on the teeth to be treated at maximum 3 on visual analog scale (10 = maximum) – Patient wishes to be treated in this clinical trial after oral information by the operator and after signing the informed patient form Exclusion Criteria:

  • Allergies to ingredients of the materials under investigation (monomers) – Do not meet all inclusion criteria above – Have medical complications (organ transplants, long term antibiotic or steroid treatment, cancer or are immunocompromised) or disabilities rendering them unable to tolerate the time required to complete the restorations or to provide adequate oral hygiene – Suffer from xerostomia either by taking medications known to produce xerostomia or those with radiation induced xerostomia or Sjogren's syndrome subjects – Have teeth with advanced or severe periodontitis, rampant caries or poor oral hygiene which may require extraction of the teeth to be restored – Present with any systemic or local disorders that contraindicate the dental procedures included in this study – Patients reporting having severe grinding/bruxing or clenching or in need of TMJ-related therapy – Have tooth with exposed pulp during preparation or caries removal or require indirect pulp capping – Inclusion of teeth that are non-vital or that exhibit signs of pulpal pathology (pulpitis) – If the working field cannot be maintained in a dry state for treatment

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ivoclar Vivadent AG
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Lyndon F. Cooper, Dr., Principal Investigator, University of Illinois College of Dentistry

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.